Xponance, Inc. Abiomed Inc Transaction History

Xponance, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$242.49 - $301.46 $155,678 - $193,537	642 Added 7.36%	9,359 $2.3 Million
Q2 2022 Aug 02, 2022	BUY	$224.73 - $338.64 $269,676 - $406,368	1,200 Added 15.96%	8,717 $2.16 Million
Q1 2022 Apr 20, 2022	BUY	$277.25 - $366.29 $35,765 - $47,251	129 Added 1.75%	7,517 $2.49 Million
Q4 2021 Jan 31, 2022	BUY	$300.63 - $371.35 $164,444 - $203,128	547 Added 8.0%	7,388 $2.65 Million
Q3 2021 Nov 05, 2021	SELL	$310.19 - $376.2 $60,487 - $73,359	-195 Reduced 2.77%	6,841 $2.23 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $134,507 - $179,799	512 Added 7.85%	7,036 $2.2 Million
Q1 2021 May 10, 2021	SELL	$285.92 - $355.13 $3,431 - $4,261	-12 Reduced 0.18%	6,524 $2.08 Million
Q4 2020 Feb 11, 2021	BUY	$251.88 - $324.2 $23,424 - $30,150	93 Added 1.44%	6,536 $2.12 Million
Q3 2020 Oct 26, 2020	BUY	$255.22 - $317.0 $11,229 - $13,948	44 Added 0.69%	6,443 $1.79 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $904,818 - $1.65 Million	6,399 New	6,399 $1.55 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.